483
Mohammed AnsariFDA 483 - Mohammed Ansari - September 16, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Texas Tech University Health Sciences Center in Lubbock, TX, identified a significant issue with the timely reporting of Serious Adverse Events (SAEs). The clinical investigator failed to adhere to the investigational plan and internal procedures, resulting in multiple instances of delayed SAE reporting to the Institutional Review Board (IRB). This indicates a lapse in human subject protection protocols.
Open in Dashboard
ID · 87083e1a-f786-42a6-9e15-b4126ade16ca